標題: Titlebook: Complications of Cirrhosis; Evaluation and Manag Andrew P. Keaveny,Andrés Cárdenas Book 2015 Springer International Publishing Switzerland [打印本頁] 作者: Ingrown-Toenail 時間: 2025-3-21 18:33
書目名稱Complications of Cirrhosis影響因子(影響力)
書目名稱Complications of Cirrhosis影響因子(影響力)學科排名
書目名稱Complications of Cirrhosis網(wǎng)絡公開度
書目名稱Complications of Cirrhosis網(wǎng)絡公開度學科排名
書目名稱Complications of Cirrhosis被引頻次
書目名稱Complications of Cirrhosis被引頻次學科排名
書目名稱Complications of Cirrhosis年度引用
書目名稱Complications of Cirrhosis年度引用學科排名
書目名稱Complications of Cirrhosis讀者反饋
書目名稱Complications of Cirrhosis讀者反饋學科排名
作者: 善于 時間: 2025-3-21 22:15 作者: Pedagogy 時間: 2025-3-22 02:48 作者: BARK 時間: 2025-3-22 06:02 作者: 搜集 時間: 2025-3-22 12:21
Prediction of Complications of Cirrhosis: Molecular Biomarkerst of complications is limited or has not been specifically evaluated. In this chapter, we review the existing knowledge on molecular markers for portal hypertension, ascites, and variceal bleeding; bacterial translocation and infections; hepatorenal syndrome (HRS) and acute kidney injury (AKI); and hepatic encephalopathy (HE).作者: 啤酒 時間: 2025-3-22 14:58 作者: 啤酒 時間: 2025-3-22 19:53 作者: AUGER 時間: 2025-3-22 21:54
Acute Variceal Bleedingt chapter focuses on the management of patients with acute variceal bleeding, including general management and hemostatic therapies, as well as the available treatments for refractory cases. New developments including early TIPS placement and esophageal metal stents are discussed.作者: 外表讀作 時間: 2025-3-23 01:27
Methods of Structural Reliability,volume paracentesis with albumin replacement and in some cases a transjugular intrahepatic portosystemic shunt. This chapter focuses on the practical aspects of the treatment of patients with ascites and cirrhosis.作者: 背帶 時間: 2025-3-23 07:59 作者: Harpoon 時間: 2025-3-23 12:26 作者: 淺灘 時間: 2025-3-23 16:37
Tanvir Mustafy,Md. Tauhid Ur Rahman cirrhosis. Furthermore, the ultimate cure of decompensated cirrhosis is liver transplant, which requires demonstration of urgency using prognostic modeling for priority. This chapter outlines the clinical complications of cirrhosis, their prognoses, and prognostic tools to stratify severity of patients with cirrhosis.作者: 委派 時間: 2025-3-23 19:41
David Ruppert,David S. Matteson search for an alternative to liver biopsy has led to the development of noninvasive markers in the blood for hepatic fibrosis. In this chapter, we review both nonspecific and specific biomarkers of fibrosis.作者: Cloudburst 時間: 2025-3-23 23:56
Probability and Statistical Models,e management of the patient who suffers from cirrhosis because it is associated with a high rate of morbidity and mortality. Screening guidelines and different modalities for primary and secondary prophylaxis are described in this chapter.作者: SHRIK 時間: 2025-3-24 04:19 作者: cultivated 時間: 2025-3-24 09:21 作者: 含糊其辭 時間: 2025-3-24 11:37
Esophageal Varices: Primary and Secondary Prophylaxise management of the patient who suffers from cirrhosis because it is associated with a high rate of morbidity and mortality. Screening guidelines and different modalities for primary and secondary prophylaxis are described in this chapter.作者: MOT 時間: 2025-3-24 16:40 作者: NATTY 時間: 2025-3-24 22:25
Book 2015s pertaining to the delivery of quality care in this patient population..Written by experts in their fields, .Complications of Cirrhosis: Evaluation and Management. serves as a valuable resource for practitioners and physicians-in-training on the subject of cirrhosis..作者: ordain 時間: 2025-3-25 00:44
The Product Moment Correlation,which has led to the recognition that patients with PHG versus GAVE require different management strategies. In this chapter, we review the pathophysiology, diagnosis, management, and future directions in the management in PHG and GAVE.作者: BILIO 時間: 2025-3-25 03:30 作者: 亂砍 時間: 2025-3-25 08:23 作者: aspect 時間: 2025-3-25 11:50 作者: Arctic 時間: 2025-3-25 18:07
Reversal of Cirrhosishe main molecular mechanisms that mediate the removal of the fibrosis scar. Key players in this process are hepatic stellate cells, macrophages, metalloproteinases, and their inhibitors. This chapter summarizes the current evidence that cirrhosis is potentially reversible, the mechanisms leading to 作者: 執(zhí)拗 時間: 2025-3-25 23:00 作者: 枯燥 時間: 2025-3-26 02:28 作者: reception 時間: 2025-3-26 05:22
Hepatorenal Syndromed lipocalin (NGAL), may be useful in the differential diagnosis of kidney failure in cirrhosis. HRS may develop spontaneously or following a precipitating event, particularly bacterial infections. The best treatment approach for patients with type 1 HRS is pharmacological therapy with vasoconstricto作者: 過多 時間: 2025-3-26 08:28 作者: landmark 時間: 2025-3-26 16:30 作者: nutrients 時間: 2025-3-26 19:10 作者: CEDE 時間: 2025-3-26 22:11
Random Variables and Their Distribution, on the appropriateness of the word “cirrhosis”, which implies almost automatically a rapid and adverse prognosis in an era when increasing therapeutic options are rapidly emerging. In this context perhaps it whould be more appropriate, to address this problem, discussing about “cirrhoses” rather th作者: Monocle 時間: 2025-3-27 01:18
Sum and Functions of Random Variables,ted cirrhosis. A final stage characterized by multi-organ failure, termed “acute-on-chronic” liver failure, is associated with the worst prognosis. This chapter provides an overview of the various prognostic stages and their significance for patients with cirrhosis.作者: Aura231 時間: 2025-3-27 08:03 作者: Urologist 時間: 2025-3-27 10:58 作者: CLAY 時間: 2025-3-27 14:21 作者: iodides 時間: 2025-3-27 19:14
Carmen Batanero,Manfred Borovcnikd lipocalin (NGAL), may be useful in the differential diagnosis of kidney failure in cirrhosis. HRS may develop spontaneously or following a precipitating event, particularly bacterial infections. The best treatment approach for patients with type 1 HRS is pharmacological therapy with vasoconstricto作者: 投射 時間: 2025-3-28 00:49 作者: Comprise 時間: 2025-3-28 04:06 作者: 珊瑚 時間: 2025-3-28 07:59
Andrew P. Keaveny,Andrés CárdenasAddresses topical concerns in the management of patients with cirrhosis.Features a wide array of illustrations and color photographs.Written by experts in their fields.Includes supplementary material:作者: LIEN 時間: 2025-3-28 11:53
http://image.papertrans.cn/c/image/231767.jpg作者: constitute 時間: 2025-3-28 16:32 作者: Regurgitation 時間: 2025-3-28 19:11 作者: 滴注 時間: 2025-3-29 02:27 作者: 巨頭 時間: 2025-3-29 06:01 作者: 小丑 時間: 2025-3-29 07:36
Xavier Descombes,Eugène Pechersky is fundamental in order to improve patient management and prognosis. A number of studies have attempted to identify clinical and molecular markers that accurately stage liver cirrhosis and help detect clinical complications. Currently, there are no commercially available molecular biomarkers that c作者: 友好關系 時間: 2025-3-29 14:38
Tanvir Mustafy,Md. Tauhid Ur Rahmanlications. Timely intervention can limit the impact of these complications, which makes recognition and prognostication paramount in the management of cirrhosis. Furthermore, the ultimate cure of decompensated cirrhosis is liver transplant, which requires demonstration of urgency using prognostic mo作者: 棲息地 時間: 2025-3-29 18:23 作者: NAIVE 時間: 2025-3-29 23:43 作者: 輕快走過 時間: 2025-3-30 01:38
Ainura Tursunalieva,Irene Hudson,Geoff Chaserogate marker in chronic liver diseases. It reflects disease severity and has strong prognostic value with regard to survival and decompensation in patients with compensated cirrhosis, during acute bleeding and before liver resection surgery. Furthermore, repeat measurements of the HVPG provide uniq作者: PTCA635 時間: 2025-3-30 06:07 作者: aggrieve 時間: 2025-3-30 10:10 作者: 稀釋前 時間: 2025-3-30 14:55 作者: Oratory 時間: 2025-3-30 18:09 作者: 事先無準備 時間: 2025-3-30 23:34 作者: 排他 時間: 2025-3-31 04:25
Methods of Structural Reliability,eased morbidity and mortality. About half of patients with previously compensated cirrhosis are expected to develop ascites within 10 years of diagnosis. One of the most important steps in the initial assessment of patients with ascites is referral of appropriate candidates for liver transplantation作者: gusher 時間: 2025-3-31 08:54
